Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H25NO4 |
| Molecular Weight | 355.4275 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CCN1CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35
InChI
InChIKey=OHKCLOQPSLQCQR-MBPVOVBZSA-N
InChI=1S/C21H25NO4/c1-12(2)6-9-22-10-8-20-17-13-3-4-14(23)18(17)26-19(20)15(24)5-7-21(20,25)16(22)11-13/h3-4,6,16,19,23,25H,5,7-11H2,1-2H3/t16-,19+,20+,21-/m1/s1
| Molecular Formula | C21H25NO4 |
| Molecular Weight | 355.4275 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Nalmexone is an opioid partial agonist or mixed agonist-antagonist with both analgesic and narcotic antagonist properties. In preclinical models parenteral nalmexone was a moderately active antagonist and therefore might have low abuse potential. At the same time, early work in man indicated analgesic
activity in doses above 20 mg.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4557582
Doses of 5 mg and 10 mg of morphine were
compared with 15 mg and 30 mg of nalmexone in the first study and with 40 mg and 60 mg of nalmexone in the second one. Each patient was given a "round" of 4 medications, a low and high dose of morphine with a low and high dose of nalmexone, to establish and compare doseeffect curves of the 2 drugs. The medications were prepared in identical ampules and administered intramuscularly under random, double-blind conditions.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:42 GMT 2025
by
admin
on
Mon Mar 31 18:09:42 GMT 2025
|
| Record UNII |
AIB278UKIG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C681
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AIB278UKIG
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
Nalmexone
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
C83978
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
SUB09140MIG
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
2443
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
100000084461
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
C005300
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111160
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
16676-26-9
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
5360516
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY | |||
|
DTXSID80168172
Created by
admin on Mon Mar 31 18:09:42 GMT 2025 , Edited by admin on Mon Mar 31 18:09:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |